Literature DB >> 7607117

Cytokine production in blood mononuclear cells from epileptic patients.

R Pacifici1, L Paris, S Di Carlo, A Bacosi, S Pichini, P Zuccaro.   

Abstract

Although convulsive disorders have been associated with immune abnormalities, little is known about cytokine production in epileptic patients. We evaluated the concentrations of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta), interleukin-2 (IL-2), and interleukin-6 (IL-6) secreted by peripheral blood mononuclear cells (PBMC) from epileptic patients. The PBMC collected from epileptic patients, as compared with those of a control group, showed greater production of IL-1 alpha, IL-1 beta, and IL-6 in response to in vitro stimulation with mitogen. There was no statistical difference among patients treated with different antiepileptic drugs (AEDs). Significantly greater IL-2 production was observed in PBMC from carbamazepine (CBZ)-treated patients as compared with both the control group or with valproate and phenobarbital (PB)-treated patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607117     DOI: 10.1111/j.1528-1157.1995.tb01013.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

Review 1.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

3.  Inflammation and epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2005 Jan-Feb       Impact factor: 7.500

4.  Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines.

Authors:  Anne A Kan; Wilco de Jager; Marina de Wit; Cobi Heijnen; Mirjam van Zuiden; Cyrill Ferrier; Peter van Rijen; Peter Gosselaar; Ellen Hessel; Onno van Nieuwenhuizen; Pierre N E de Graan
Journal:  J Neuroinflammation       Date:  2012-08-30       Impact factor: 8.322

5.  Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus.

Authors:  Raoul Sutter; Sarah Tschudin-Sutter; Leticia Grize; Andreas F Widmer; Stephan Marsch; Stephan Rüegg
Journal:  Crit Care       Date:  2011-11-18       Impact factor: 9.097

6.  Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy.

Authors:  Kenneth I Strauss; Kost V Elisevich
Journal:  J Neuroinflammation       Date:  2016-10-13       Impact factor: 8.322

Review 7.  Inflammation in epileptogenesis after traumatic brain injury.

Authors:  Kyria M Webster; Mujun Sun; Peter Crack; Terence J O'Brien; Sandy R Shultz; Bridgette D Semple
Journal:  J Neuroinflammation       Date:  2017-01-13       Impact factor: 8.322

8.  Neural circuit mechanisms of post-traumatic epilepsy.

Authors:  Robert F Hunt; Jeffery A Boychuk; Bret N Smith
Journal:  Front Cell Neurosci       Date:  2013-06-18       Impact factor: 5.505

Review 9.  Markers in Status Epilepticus Prognosis.

Authors:  Ayham Alkhachroum; Caroline A Der-Nigoghossian; Clio Rubinos; Jan Claassen
Journal:  J Clin Neurophysiol       Date:  2020-09       Impact factor: 2.590

10.  Procalcitonin and mortality in status epilepticus: an observational cohort study.

Authors:  Raoul Sutter; Martina Valença; Sarah Tschudin-Sutter; Stephan Rüegg; Stephan Marsch
Journal:  Crit Care       Date:  2015-10-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.